Doxapram Treatment and Diaphragmatic Activity in Preterm Infants

BACKGROUND: Doxapram is a treatment option for severe apnea of prematurity (AOP). However, the effect of doxapram on the diaphragm, the main respiratory muscle, is not known. OBJECTIVES: To investigate the effect of doxapram on diaphragmatic activity measured with transcutaneous electromyography of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neonatology
Autors principals: de Waal, Cornelia G., Hutten, Gerard J., Kraaijenga, Juliette V., de Jongh, Frans H., van Kaam, Anton H.
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2019
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425813/
https://ncbi.nlm.nih.gov/pubmed/30352445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493359
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars